University of Manchester

TaBriX, University of Manchester and TB Alliance to develop drug-resistant TB treatments

TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.

Read More →

Indonesian study reveals missed diagnosis of fungal infections in treated TB patients, with global implications

A study of tuberculosis patients in six Jakarta hospitals has revealed up to 13 per cent of them had fungal lung infection – or aspergillosis – at the end of their treatment.

Read More →

Scientists develop new drug treatment for TB

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.

Read More →

Page 1 of 1 · Total posts: 3